chr5-150124785-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002609.4(PDGFRB):​c.1854G>A​(p.Thr618Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0321 in 1,609,566 control chromosomes in the GnomAD database, including 1,152 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 91 hom., cov: 32)
Exomes 𝑓: 0.033 ( 1061 hom. )

Consequence

PDGFRB
NM_002609.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -4.17

Publications

7 publications found
Variant links:
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
PDGFRB Gene-Disease associations (from GenCC):
  • acroosteolysis-keloid-like lesions-premature aging syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • myofibromatosis, infantile, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • basal ganglia calcification, idiopathic, 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • bilateral striopallidodentate calcinosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary progressive mucinous histiocytosis
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 5-150124785-C-T is Benign according to our data. Variant chr5-150124785-C-T is described in ClinVar as Benign. ClinVar VariationId is 473404.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.17 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0527 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDGFRBNM_002609.4 linkc.1854G>A p.Thr618Thr synonymous_variant Exon 13 of 23 ENST00000261799.9 NP_002600.1 P09619-1Q59F04
PDGFRBNM_001355016.2 linkc.1662G>A p.Thr554Thr synonymous_variant Exon 12 of 22 NP_001341945.1
PDGFRBNM_001355017.2 linkc.1371G>A p.Thr457Thr synonymous_variant Exon 13 of 23 NP_001341946.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDGFRBENST00000261799.9 linkc.1854G>A p.Thr618Thr synonymous_variant Exon 13 of 23 1 NM_002609.4 ENSP00000261799.4 P09619-1
PDGFRBENST00000520579.5 linkn.*1168G>A non_coding_transcript_exon_variant Exon 13 of 23 1 ENSP00000430026.1 E5RH16
PDGFRBENST00000520579.5 linkn.*1168G>A 3_prime_UTR_variant Exon 13 of 23 1 ENSP00000430026.1 E5RH16
PDGFRBENST00000520229.1 linkn.123G>A non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.0254
AC:
3869
AN:
152052
Hom.:
91
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00585
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0230
Gnomad ASJ
AF:
0.0806
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.0580
Gnomad FIN
AF:
0.0157
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0361
Gnomad OTH
AF:
0.0326
GnomAD2 exomes
AF:
0.0315
AC:
7833
AN:
248748
AF XY:
0.0349
show subpopulations
Gnomad AFR exome
AF:
0.00540
Gnomad AMR exome
AF:
0.0169
Gnomad ASJ exome
AF:
0.0795
Gnomad EAS exome
AF:
0.000273
Gnomad FIN exome
AF:
0.0160
Gnomad NFE exome
AF:
0.0363
Gnomad OTH exome
AF:
0.0357
GnomAD4 exome
AF:
0.0327
AC:
47729
AN:
1457398
Hom.:
1061
Cov.:
29
AF XY:
0.0343
AC XY:
24859
AN XY:
725178
show subpopulations
African (AFR)
AF:
0.00569
AC:
190
AN:
33416
American (AMR)
AF:
0.0178
AC:
797
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.0812
AC:
2114
AN:
26044
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39690
South Asian (SAS)
AF:
0.0585
AC:
5036
AN:
86060
European-Finnish (FIN)
AF:
0.0185
AC:
970
AN:
52486
Middle Eastern (MID)
AF:
0.0673
AC:
384
AN:
5708
European-Non Finnish (NFE)
AF:
0.0326
AC:
36162
AN:
1109100
Other (OTH)
AF:
0.0343
AC:
2068
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1908
3816
5725
7633
9541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1298
2596
3894
5192
6490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0254
AC:
3869
AN:
152168
Hom.:
91
Cov.:
32
AF XY:
0.0247
AC XY:
1836
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.00583
AC:
242
AN:
41522
American (AMR)
AF:
0.0231
AC:
353
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0806
AC:
280
AN:
3472
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5140
South Asian (SAS)
AF:
0.0583
AC:
281
AN:
4824
European-Finnish (FIN)
AF:
0.0157
AC:
167
AN:
10620
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0361
AC:
2452
AN:
67980
Other (OTH)
AF:
0.0323
AC:
68
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
195
389
584
778
973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0349
Hom.:
49
Bravo
AF:
0.0238
Asia WGS
AF:
0.0190
AC:
66
AN:
3478
EpiCase
AF:
0.0402
EpiControl
AF:
0.0427

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
Nov 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myofibromatosis, infantile, 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myeloproliferative disorder, chronic, with eosinophilia Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile myofibromatosis;C1866182:Acroosteolysis-keloid-like lesions-premature aging syndrome;C3554321:Basal ganglia calcification, idiopathic, 4;C4225270:Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
2.1
DANN
Benign
0.74
PhyloP100
-4.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56072663; hg19: chr5-149504348; COSMIC: COSV55800032; COSMIC: COSV55800032; API